Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines
✍ Scribed by Patricia García-López; Mauricio Rodríguez-Dorantes; Enrique Pérez-Cárdenas; Marco Cerbón; Alejandro Mohar-Betancourt
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 323 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In this study the ability of the new pure anti-estrogen IcI 182,780 to modulate the cytotoxic action of adriamycin (ADR) on parental and ADR-resistant MCF-7 (MCF-7 ADRr) human breast-cancer cells was investigated and compared with that of tamoxifen (TAM). TAM enhanced ADR cytotoxicity in MCF-7 ADRr
## Abstract Studies were performed to determine whether novobiocin can be used to enhance cisplatin (CDDP) cytotoxicity in a human small‐cell lung carcinoma cell line, GLC~4~/CDDP, resistant to CDDP. Continuous incubation with novobiocin enhanced the cytotoxicity of CDDP treatment 1.9‐fold in the p
We have compared the effects of a broad range of clinically relevant concentrations (0.1 to 10 M) of the steroidal pure anti-estrogen ICI 182,780 and the non-steroidal partial antiestrogen tamoxifen (TAM) on cell proliferation and induction of apoptosis in the estrogen receptor (ER)-negative ovarian